PHILADELPHIA, March 25, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female ...

Please provide your email address to receive an email when new articles are posted on . Pivmecillinam was approved for uncomplicated urinary tract infections for women. Pivmecillinam led to higher ...

GSK said the U.S. Food and Drug Administration approved its Blujepa oral antibiotic for the treatment of female adults and children with uncomplicated urinary tract infections. The pharmaceutical ...

The U.S. FDA approved UtilityTherapeutics Ltd.’s Pivya (pivmecillinam), an oral prodrug of injectable mecillinam, on its April 24 PDUFA date for female adults with uncomplicated urinary tract ...